Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study

被引:8
作者
Prins, Jelmer R. [1 ]
Holvast, Floor [2 ]
van 't Hooft, Janneke [3 ]
Bos, Arend F. [4 ]
Ganzevoort, Jan Willem [3 ]
Scherjon, Sicco A. [1 ]
Robertson, Sarah A. [5 ,6 ]
Gordijn, Sanne J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol,Dept Pediat, Groningen, Netherlands
[5] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[6] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
关键词
immune modulation; therapy; prevention; pregnancy; core outcome set; COS; REGULATORY T-CELLS; ADOPTIVE TRANSFER; IMMUNE; INFLAMMATION; MODULATION; CONSENSUS;
D O I
10.1136/bmjopen-2018-021619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation interventions as preventive or therapeutic strategies for pregnancy complications holds promise. Several studies sought to evaluate the safety and effectiveness of various approaches. However, a limitation is the high variability in clinical and immune outcomes that are reported. We, therefore, aim to develop a core outcome set for application to studies of immune modulation in pregnancy (COSIMPREG). Methods and analysis We will use a stepwise approach to develop a COSIMPREG. First, we will perform a systematic review to identify reported outcomes. For this review, Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. Second, we will use the Delphi method to develop a preliminary COSIMPREG. In three rounds, the outcomes of the systematic review will be scored. A panel comprising experts from relevant disciplines and diverse geographical locations will be assembled until a sufficient quality of the panel is reached. We will use predefined decision rules for outcomes. After each round outcomes, including scores, will be returned to the panel for further refinement. The outcomes not excluded after the third round will be taken to a consensus meeting. In this meeting, experts from all relevant disciplines will discuss and finalise the COSIMPREG. Ethics and dissemination For this study ethical approval is not required. The systematic review will be published in an appropriate open access reproductive immunology journal. Once the COSIMPREG is finalised, it will be published in an open access reproductive immunology journal, and disseminated at appropriate international meetings, as well as through relevant research and scientific societies. Experts involved in the Delphi study will be asked to give informed consent.
引用
收藏
页数:6
相关论文
共 23 条
[1]   Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth [J].
Chin, Peck Yin ;
Dorian, Camilla L. ;
Hutchinson, Mark R. ;
Olson, David M. ;
Rice, Kenner C. ;
Moldenhauer, Lachlan M. ;
Robertson, Sarah A. .
SCIENTIFIC REPORTS, 2016, 6
[2]  
Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432
[3]   Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials [J].
Deng, Yaxiong ;
Wang, Zijun ;
Chang, Christopher ;
Lu, Liwei ;
Lau, Chak Sing ;
Lu, Qianjin .
HUMAN IMMUNOLOGY, 2017, 78 (02) :120-128
[4]   Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies [J].
Diamond, Ivan R. ;
Grant, Robert C. ;
Feldman, Brian M. ;
Pencharz, Paul B. ;
Ling, Simon C. ;
Moore, Aideen M. ;
Wales, Paul W. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (04) :401-409
[5]   B cells: depletion or functional modulation in rheumatic diseases [J].
Doerner, Thomas ;
Lipsky, Peter E. .
CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (02) :228-236
[6]   Core outcome sets in women's and newborn health: a systematic review [J].
Duffy, J. M. N. ;
Rolph, R. ;
Gale, C. ;
Hirsch, M. ;
Khan, K. S. ;
Ziebland, S. ;
McManus, R. J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (10) :1481-1489
[7]   Consensus definition of fetal growth restriction: a Delphi procedure [J].
Gordijn, S. J. ;
Beune, I. M. ;
Thilaganathan, B. ;
Papageorghiou, A. ;
Baschat, A. A. ;
Baker, P. N. ;
Silver, R. M. ;
Wynia, K. ;
Ganzevoort, W. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 48 (03) :333-339
[8]   Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? [J].
Guerin, Leigh R. ;
Prins, Jelmer R. ;
Robertson, Sarah A. .
HUMAN REPRODUCTION UPDATE, 2009, 15 (05) :517-535
[9]   Immune modulation treatments-where is the evidence? [J].
Hviid, Malene Meisner ;
Macklon, Nick .
FERTILITY AND STERILITY, 2017, 107 (06) :1284-1293
[10]   Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy [J].
Ibrahim, Tarek ;
Przybyl, Lukasz ;
Harmon, Ashlyn C. ;
Amaral, Lorena M. ;
Faulkner, Jessica L. ;
Cornelius, Denise C. ;
Cunningham, Mark W. ;
Huenig, Thomas ;
Herse, Florian ;
Wallukat, Gerd ;
Dechend, Ralf ;
LaMarca, Babbette .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2017, 78 (05)